• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Ionis

arrow bullseye target on target
Pharma

Arrowhead strikes true with first FDA approval

Complicating things is the fact that Arrowhead’s first marketed product will now compete directly with the inaugural launch from its legal foe, Ionis.
Fraiser Kansteiner Nov 18, 2025 3:44pm
home run

Ionis' Tryngolza win in sHTG sends shares soaring by 27%

Sep 2, 2025 11:30am
Three blocks displaying from left to right a person a handshake and another person

Ionis, Arrowhead sponsor new triglyceride education group

Mar 28, 2025 10:10am
Ionis headquarters

Tryngolza's FDA approval marks 'pivotal moment' for Ionis: CEO

Dec 20, 2024 8:32am
alphabet blocks

Inside #FierceMadness winner Wainua's 'phonetic appeal'

Apr 15, 2024 4:16pm
Biogen

FDA awards Biogen's ALS drug Qalsody an accelerated approval

Apr 25, 2023 2:28pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings